StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SONM$5.41+14.38%
Fair $5.41+0.0%

SONM

DNA X, Inc.

Technology / Software - InfrastructureNasdaqCM

$5.41

+0.68 (+14.38%)

Fairly Valued+0.0%Fair Value $5.41Fund rank 30/100 · Data gapFallback financials|
SA 23/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 25%

FCF escenarios

weak_data · normalized FCF $-8.7M · quality 59.0/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

23/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 8Warnings: 1unknown: 8
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 3.1%, below the 5% threshold
Thesis & Journal · SONMLocal privado en este navegador · DNA X, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

307.1%

↑

Gross Margin

N/A

•

Debt/Equity

-0.75

↓
52-Week Range$5
$3$39

TradingView lightweight chart

SONM price, volumen y niveles de valoración

Último $5.410Periodo -100.0%
Fair value: $5.410

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2018–2025 · 7 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

—

FCF / Net income

1.14x

Latest source

Provider fallback

Margin decomposition

Último año: revenue — · net income $-20.7M · FCF $-23.5M

2018-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

—— pts

FCF margin

—— pts
MetricTTM
2025
2024
2023
2022
2021
2020
2019
2018
Income Statement
Revenue———$93.6M$69.8M$54.6M$64.0M$116.3M$135.7M
Net Income$-20.7M$-20.7M$-33.6M$-90000.00$-14.1M$-38.6M$-29.9M$-25.8M$1.3M
EBITDA$-2.2M$-2.2M$703000.00$2.5M$-11.4M$-35.9M$-26.5M$-18.9M$7.2M
EPS-28.58-28.58-128.37-0.36-4.90-734.40———
Gross Margin———20.6%16.6%11.8%23.8%29.7%35.4%
Operating Margin———0.5%-20.5%-69.6%-45.7%-19.3%4.0%
Net Margin———-0.1%-20.2%-70.8%-46.8%-22.2%0.9%
Balance Sheet
Debt/Equity-0.75-0.75—0.000.010.000.010.012.58
Current Ratio0.760.76———————
Cash Flow
Free Cash Flow$-23.5M$-23.5M$-8.7M$-4.1M$-12.4M$-38.5M$-10.6M$-34.5M$3.1M
Returns
ROE307.1%307.1%590.3%-0.4%-70.3%-207.3%-105.4%-101.2%24.9%
Valuation
EV/EBITDA——13.819.45—————
P/B———1.4812.58————
Growth & Yield
Revenue Growth———34.1%—-14.7%-45.0%-14.3%—
EPS Growth77.7%77.7%-35558.3%92.7%—————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -68.4%

Total return

-68.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-128.37 → -28.58

Residual

-68.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-68.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.